Effect of height and BMI on whole-body and local free convection coefficients for male and female manikins. by Shri H. Viswanathan (20685553)

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes with Alirocumab: Post-Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial by Gregory G. Schwartz (20599125)

“…<a href="" target="_blank">OR for NOD for 25% and 50% lipoprotein(a) reductions were 1.12 (95% CI 1.01</a>-1.23) and 1.24 (1.02-1.52). …”

Image_2_PTEN Inhibition Protects Against Experimental Intracerebral Hemorrhage-Induced Brain Injury Through PTEN/E2F1/β-Catenin Pathway.jpeg by Dan Zhao (285025)

“…We demonstrate that bpV[pic] attenuates ICH-induced brain injury in vivo and hemin-induced neuron injury in vitro. The expression of E2F1 was increased, but β-catenin expression was decreased after ICH, and the altered expressions of E2F1 and β-catenin after ICH were blocked by bpV[pic] treatment. …”

Image_1_PTEN Inhibition Protects Against Experimental Intracerebral Hemorrhage-Induced Brain Injury Through PTEN/E2F1/β-Catenin Pathway.jpeg by Dan Zhao (285025)

“…We demonstrate that bpV[pic] attenuates ICH-induced brain injury in vivo and hemin-induced neuron injury in vitro. The expression of E2F1 was increased, but β-catenin expression was decreased after ICH, and the altered expressions of E2F1 and β-catenin after ICH were blocked by bpV[pic] treatment. …”

Archetype connectivity. by Giulio Ruffini (383994)

CD1d deficiency worsens metabolic parameters when mice are fed a choline-deficient diet. by Maya E. Kotas (203189)

“…E) Abnormal glucose tolerance observed in <i>CD1d^−/−</i> on choline-deficient diet with F) decreased fasting plasma glucose. …”

(A) Rate of mature forest loss at each time interval, estimated from single-date image classification by M E Fagan (557038)

YFV-Asibi NS4A-5 promotes replication of the cap0 virus. by Anja vom Hemdt (19787189)

Change of SMAD4 after TGFβ inhibitor /activator treatment. by Jingping Ge (636557)

“…Protein levels were measured by Western blot analysis. A) Decrease of total p-SMAD2 after SB431542 treatment in all iPSCs, and increase of p-SMAD2 in both DBA iPSCs after the TGFβ1 treatment. …”

FOXO3a mediates the downregulation of GR induced by chronic exposure to GCs. by Shi-Ying Yuan (2937669)

“…<p>(A) Representative western blot images and summarized data showing the decreased expression of LKB1 (A) and the inhibitory phosphorylation of FOXO3a-Thr32 (B) in cultured astrocytes (n = 6 for each group). …”

Image 1_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Notably, E2-induced increased B cell antibody responses conferred greater protection from HSV-2 challenge compared to placebo mice as evidenced by 2–3 logs decreased viral titers in the vaginal tract and 20% mice with genital pathology compared to 80% in placebo group, indicating better protection in E2-treated mice. …”

Image 2_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Notably, E2-induced increased B cell antibody responses conferred greater protection from HSV-2 challenge compared to placebo mice as evidenced by 2–3 logs decreased viral titers in the vaginal tract and 20% mice with genital pathology compared to 80% in placebo group, indicating better protection in E2-treated mice. …”

Image 5_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Notably, E2-induced increased B cell antibody responses conferred greater protection from HSV-2 challenge compared to placebo mice as evidenced by 2–3 logs decreased viral titers in the vaginal tract and 20% mice with genital pathology compared to 80% in placebo group, indicating better protection in E2-treated mice. …”

Image 3_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Notably, E2-induced increased B cell antibody responses conferred greater protection from HSV-2 challenge compared to placebo mice as evidenced by 2–3 logs decreased viral titers in the vaginal tract and 20% mice with genital pathology compared to 80% in placebo group, indicating better protection in E2-treated mice. …”

Image 4_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Notably, E2-induced increased B cell antibody responses conferred greater protection from HSV-2 challenge compared to placebo mice as evidenced by 2–3 logs decreased viral titers in the vaginal tract and 20% mice with genital pathology compared to 80% in placebo group, indicating better protection in E2-treated mice. …”

Phosphodiesterase Inhibition Increases CREB Phosphorylation and Restores Orientation Selectivity in a Model of Fetal Alcohol Spectrum Disorders by Thomas E. Krahe (260878)

Individual shift of Ising temperature (top), LZW (middle), and BDM (bottom) complexity induced by LSD (empirical data). by Giulio Ruffini (383994)

Individual shift of LZW (top row) and BDM (bottom) complexity in LSD and placebo conditions estimated from synthetic data generated by the archetype model. by Giulio Ruffini (383994)

Salvia fruticosa Induces Vasorelaxation in Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway by Anwar, M. Akhtar

“…Prior exposure to PI3K inhibitors, wortmannin (0.1 µM) or LY294002 (10 µM), decreased cGMP accumulation and attenuated the SF-induced vasorelaxation by approximately 50% (Rmax). …”
Get full text
Get full text

Identification of novel pathogenic mutations in <i>ATP6V0A4</i> associated with distal renal tubular acidosis and analysis of wild-type expression in glomerular disease by Yaru Jiang (17458815)

“…Notably, patients with <i>ATP6V0A4</i> mutations were diagnosed at a younger age (mean 0.5 years) and exhibited more severe renal impairment, including reduced estimated glomerular filtration rate (eGFR), indicating heightened susceptibility to kidney damage. …”